FDA product code QSQ: Transcutaneous Electrical Nerve Stimulator To Treat Fibromyalgia Symptoms
QSQ is the FDA product code for transcutaneous electrical nerve stimulator to treat fibromyalgia symptoms. It is a Class II device, regulated under 21 CFR 882.5888 and reviewed by the Neurology panel. Devices under QSQ reach the market by 510(k); FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.
Definition
Transcutaneous electrical nerve stimulator to treat fibromyalgia symptoms.
Classification
| Field | Value |
|---|---|
| Device name | Transcutaneous Electrical Nerve Stimulator To Treat Fibromyalgia Symptoms |
| Device class | Class II |
| Regulation | 21 CFR 882.5888 |
| Review panel | NE — Neurology |
| Medical specialty | Neurology |
| Premarket route | 510(k) |
Recalls for QSQ devices
openFDA lists no recalls for product code QSQ.
Frequently asked questions
What is FDA product code QSQ?
QSQ is the FDA product code for transcutaneous electrical nerve stimulator to treat fibromyalgia symptoms. It is a Class II device, regulated under 21 CFR 882.5888 and reviewed by the Neurology panel.
What device class is QSQ?
Class II, regulation 21 CFR 882.5888. Typical premarket route: 510(k).
Next steps
- Run an FDA pathway report with predicate devices for product code QSQ
- Run a recall and safety report across every QSQ manufacturer
- Watch product code QSQ for new clearances and recalls
Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.
All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times